Volume 95 Issue 40 | pp. 28-30
Issue Date: October 9, 2017

Cambrex bucks the pharmaceutical service trend

But the small-molecule stalwart may surprise with its next investment
Department: Business
Keywords: Outsourcing, Pharmaceutical chemicals, Cambrex

The world of pharmaceutical contract manufacturing has been rocked by a number of jarring deals of late. Thermo Fisher Scientific’s acquisition of Patheon, valued at $7.2 billion, was a shock to many industry watchers earlier this year. Lonza’s $5.5 billion purchase of Capsugel also made a stir, as did the merger of Cambridge Major Laboratories and AAIPharma Services to form Alcami. Even . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society